LevitasBio: Funding, Investors & Team (Sep 2026)
Levitas, Inc. is redefining cellular analytics with its novel platform magnetic levitation technology. Their disruptive technology overcomes the current technological limitation of cellular analysis by providing label-free, simple, and universal methods of analysis. The company's platform, the LeviCell enables studies and beneficial uses of previously inaccessible, high-value primary samples, and sensitive cell types regardless of the starting cell number, viability, or sensitivity to processing.
LevitasBio has raised $53.0M across 2 funding rounds on record, the most recent an undisclosed round of $35.0M announced in Oct 2022.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
LevitasBio Company Profile and Key Stats
Latest funding round on record: Oct 2022.
LevitasBio Funding Rounds
LevitasBio raised $18.0M in a Series B announced in Jan 2021.
1.8 years later, an undisclosed round of $35.0M was announced in Oct 2022.
LevitasBio Founders and Leadership Team
Contact details for the LevitasBio team: 1 of 1 has an email address on file.
Start 14-day free trial →LevitasBio Funding Compared to Other Biotechnology Startups
LevitasBio's latest round of $35.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like LevitasBio in Biotechnology and San Francisco
Companies Similar to LevitasBio
SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…
DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…
Solstice Oncology is a clinical stage immuno-oncology company
Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…
BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
LevitasBio Funding FAQs
What does LevitasBio do?
Levitas, Inc. is redefining cellular analytics with its novel platform magnetic levitation technology. Their disruptive technology overcomes the current technological limitation of cellular analysis by providing label-free, simple, and universal methods of analysis. The company's platform, the LeviCell enables studies and beneficial uses of previously inaccessible, high-value primary samples, and sensitive cell types regardless of the starting cell number, viability, or sensitivity to processing.
How much funding has LevitasBio raised?
LevitasBio has raised $53.0M across 2 rounds on record. The most recent is an undisclosed round of $35.0M announced in Oct 2022.
When did LevitasBio last raise funding?
LevitasBio's most recent funding round on record is an undisclosed round of $35.0M, announced in Oct 2022.
Who is the CEO of LevitasBio?
Martin Pieprzyk is listed as CEO at LevitasBio.
Where is LevitasBio headquartered?
LevitasBio is based in San Francisco, California, United States.
How many employees does LevitasBio have?
LevitasBio is in the 11-50 employee band.
How does LevitasBio's funding compare to other Biotechnology startups?
LevitasBio's latest round of $35.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.
About FundedIQ's LevitasBio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for LevitasBio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.